Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Jundishapur Journal of Microbiology
  4. Articles

  5. The Probable Role of Cytomegalovirus in Acute Myocardial Infarction
  6. Crossref

Jundishapur Journal of Microbiology

Ahvaz Jundishapur University of Medical Sciences

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Crossref


1. Cytomegalovirus driven immunosenescence—An immune phenotype with or without clinical impact?

- Cecilia Söderberg-Nauclér

- Olesja Fornara

- Afsar Rahbar

2. Productive Cytomegalovirus Infection Is Associated With Impaired Endothelial Function in ST-Elevation Myocardial Infarction

- Anna Lebedeva

- Elena Maryukhnich

- Jean-Charles Grivel

- Elena Vasilieva

- Leonid Margolis

- Alexander Shpektor

3. Viral infections in cardiometabolic risk and disease between old acquaintances and new enemies

- Cristina Vassalle

4. Human cytomegalovirus infection is correlated with atherosclerotic plaque vulnerability in carotid artery

- Dan Li

- Bo Li

- Ling Yang

- Jiawei Wang

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.